Fondation A De Rothschild — Clinical Trial Site

71 Registered trials

38 Currently recruiting

Organisation

Fondation A De Rothschild

Location

Paris, France

Identifier

ORG-100010626

Address

29 Rue Manin, 75940, France

Departments

#2103: Neurology
2500011:Ophtalmologie
304; Service d’Ophtalmologie
3202: Optalmology
7002:Neurology
75
Anesthésie Réanimation
Centre de Référence Maladies rares Maladie de WILSON
Consultation mémoire
Department of Neurology
Fondation Rothschild; Ophtalmologie
Internal Medicine
Interventional Neuroradiolology department
Médecine interne
n/a
Neurologie
Neurology
Neuroradiologie Interventionnelle
Neuroradiologue
Neurosurgery for pediatrics
Neurovasculaire
Neurovascular Unit
NRI
Ophtalmologie
ophtalmology
Ophthalmology
Pediatric neurosurgery department
Réanimation USC
Service d'ophtalmologie
service de medecine interne
Service de Neurologie
Service de Neuroradiologie interventionnelle
Service du Pr Cochereau

Clinical trials at this site (71)

Search interface

A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System with Ranibizumab in Patients … Ended

2023-507130-24-00 Neovascular age-related macular degeneration (nAMD) 5 2021-10-22
Evaluation of the effects of bosentan in the management of patients in the acute phase of acute anterior ischemic optic neuropathy. Ended

2024-518345-21-00 early stage of acute non-arteritic anterior ischemic op 5 2015-07-31
Salvage Therapy for Patients with Inadequate Response to Standard of Care Therapy in Granulomatosis with Polyangiitis Halted

2024-516687-28-00 Patients with GPA and inadequate response to standard o 5 2025-06-06
MIVAR - Milrinone Infusion for VAsospam treatment in subarachnoid hemoRrhage Ended

2024-515994-83-00 aneurysmal subarachnoid hemorrhage with a vasospasm 5 2026-01-13
Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP Ended

2024-515386-34-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2025-05-29
Efficacy of tocilizumab in the treatment of acute anterior ischemic optic neuropathy optic neuropathy in Horton's disease Ended

2024-519977-20-00 Acute Anterior Ischemic Optic Neuropathy associated wit 4 2025-01-27
Multicenter randomized controlled trial of the value of intravitreal anti-VEGF injections as initial then adjuvant treatment in Coats' disea… Ended

2024-517036-21-00 Coats' disease 4 2024-11-06
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia Ended

2023-506707-25-00 Choroidal neovascularization secondary to pathologic my 5 2024-04-09
A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke Ended

2022-501890-38-00 acute ischemic stroke 4 2024-02-16
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants with Moderate-to-Severe Thy… Ended

2023-503669-50-00 Moderate-to-Severe Thyroid Eye Disease 5 2023-12-27
Ecopipam Tablets to Study Tourette’s Disorder in Children, Adolescents and Adults (D1AMOND) Ended

2023-503494-38-00 Tourette’s Disorder 5 2023-07-20
Phase 2a, Random, double masked, Placebo-controlled, side by side group, multiple center study evaluating the effectiveness and safety of ST… Ended

2024-517104-11-00 Fuchs Endothelial Corneal Dystrophy (FECD) 4 2023-06-08
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
Glenzocimab for REperfusion in the setting of Endovascular therapy for brain infarctioN Ended

2024-514352-32-00 Acute ischemic stroke 10 2023-01-03
Phase 2b Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis Ended

2024-514975-16-00 Non-infectious, Intermediate-, Posterior- or Pan-uveiti 4 2022-12-22
An Open-Label Extension Study for Patients who Previously Completed Study ISEE2008 (GATHER2) Ended

2024-515185-13-00 geographic atrophy 5 2022-12-21
Evaluation of the efficacy of intra venous dornase alfa (Pulmozyme®) on arterial recanalization in post-thrombectomy angiography in patients… Ended

2024-515831-31-00 Ischemic stroke 4 2022-08-19
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Ended

2023-508571-37-00 Geographic atrophy (GA) secondary to Age-related Macula 4 2022-04-29
Spontaneous Retinal Arterial Pulsations (SRAPs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVOs) in patients treated o… Ended

2024-516681-10-01 central retinal vein occlusions 4 2021-03-24
Prospective Study to Characterize the Pharmacokinetics and Pharmacodynamics of Cufence (Trientine Dihydrochloride) in Wilson Disease Patient… Ended

2024-516431-27-00 Wilson’s Disease 6 2021-02-23
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor tolebrutinib (SAR442168) (PERSEUS) Ended

2024-514495-41-00 Primary Progressive Multiple Sclerosis 5 2020-11-04
Comparative multicenter randomized study of aflibercept versus placebo in macular telangiectasia type 1 Ended

2024-511885-35-00 macular telangiectasia type 1 5 2019-07-03
Glenzocimab in Anterior stroke with Large Ischemic Core eligible for Endovascular therapy Ended

2023-509615-92-00 Ischemic stroke with Large Core 4